Page 137 - 《中国药房》2023年16期

其他β受体阻滞剂，奈必洛尔对β1受体的高度选择性和 [11] SELEME V B，MARQUES G L，MENDES A E M，et al.
经NO介导的血管舒张特性，使其具有抗氧化、改善内皮 Nebivolol for the treatment of essential systemic arterial
功能紊乱、对性功能影响较小甚至改善以及对血糖、血 hypertension：a systematic review and meta-analysis[J].

脂代谢无不良影响等优点。除对心率影响较小之外，该 Am J Cardiovasc Drugs，2021，21（2）：165-180.
[12] LIU J Y，GUO L N，PENG W Z，et al. Efficacy and safety
药物更适用于一些特殊群体患者，包括性活跃的男性高
of nebivolol in hypertensive patients：a meta-analysis of
血压患者及合并有2型糖尿病、代谢综合征等并发症的
randomized controlled trials[J]. J Int Med Res，2020，48
高血压患者。因此，奈必洛尔用于高血压的临床治疗优
（10）：300060520931625.
势明显。
[13] VAZ-DE-MELO R O， GIOLLO-JÚNIOR L T，
参考文献 MARTINELLI D D，et al. Nebivolol reduces central blood
[ 1 ] WILLIAMS B，MANCIA G，SPIERING W，et al. 2018 pressure in stage Ⅰ hypertensive patients：experimental
ESC/ESH guidelines for the management of arterial hyper‐
single cohort study[J]. Sao Paulo Med J，2014，132（5）：
tension[J].Eur Heart J，2018，39（33）：3021-3104. 290-296.
[ 2 ] FONGEMIE J，FELIX-GETZIK E. A review of nebivolol [14] BORGHI C，ACELAJADO M C，GUPTA Y，et al. Role of
pharmacology and clinical evidence[J]. Drugs，2015，75 nebivolol in the control and management of central aortic
（12）：1349-1371. blood pressure in hypertensive patients[J]. J Hum Hyper‐
[ 3 ] CHO K I，JEON D W，AHN H S，et al. Efficacy and tens，2017，31（10）：605-610.
safety of nebivolol in Korean patients with hypertension [15] SOANKER R，NAIDU M U，RAJU S B，et al. Effect of
by age and sex：a subanalysis from the BENEFIT-KOREA beta-1-blocker，nebivolol，on central aortic pressure and
study[J]. Clin Hypertens，2021，27（1）：9. arterial stiffness in patients with essential hypertension[J].
[ 4 ] ALTIN C，OKYAY K，KIS M. et al. The safety and tole- Indian J Pharmacol，2012，44（3）：407-411.
rability of nebivolol in hypertensive patients with coro‐ [16] BASILE J，EGAN B，PUNZI H，et al. Risk of hospitaliza‐
nary artery disease and left ventricular ejection fraction≥ tion for cardiovascular events with β-blockers in hyperten‐
40%：a population-based cohort study[J]. Turk Kardiyol sive patients：a retrospective cohort study[J]. Cardiol
Dern Ars，2022，50（8）：568-575. Ther，2018，7（2）：173-183.
[ 5 ] ZHAO Y Z，VANHOUTTE P M，LEUNG S W. Vascular [17] HUCK D M，ROSENBERG M A，STAUFFER B L.
nitric oxide：beyond eNOS[J]. J Pharmacol Sci，2015，129 Nebivolol and incident cardiovascular events in hyperten‐
（2）：83-94. sive patients compared with nonvasodilatory beta blockers
[ 6 ] NAPOLI C，PAOLISSO G，CASAMASSIMI A，et al. [J]. J Hypertens，2022，40（5）：1019-1029.
Effects of nitric oxide on cell proliferation：novel insights [18] MANOLIS A，DOUMAS M，FERRI C，et al.Erectile dys‐
[J]. J Am Coll Cardiol，2013，62（2）：89-95. function and adherence to antihypertensive therapy-focus
[ 7 ] SHARP R P，GALES B J. Nebivolol versus other beta on β-blockers[J]. Eur J Intern Med，2020，81：1-6.
blockers in patients with hypertension and erectile dys‐ [19] BRIXIUS K，MIDDEKE M，LICHTENTHAL A，et al. Ni‐
function[J]. Ther Adv Urol，2017，9（2）：59-63. tric oxide，erectile dysfunction and beta-blocker treatment
[ 8 ] DUPREZ D A，FLOREA N，DUVAL S，et al. Effect （MR NOED study）：benefit of nebivolol versus metopro‐
of nebivolol or atenolol vs. placebo on cardiovascular lol in hypertensive men[J]. Clin Exp Pharmacol Physiol，
health in subjects with borderline blood pressure：the 2007，34（4）：327-331.
EVIDENCE study[J]. J Hum Hypertens，2017，32（1）： [20] ALDEMIR M，KELEŞ İ，KARALAR M，et al. Nebivolol
20-25. compared with metoprolol for erectile function in males
[ 9 ] DIEHL K J，STAUFFER B L，DOW C A，et al. Chronic undergoing coronary artery bypass graft[J]. Anatol J Car‐
nebivolol treatment suppresses endothelin-1-mediated va‐ diol，2016，16（2）：131-136.
soconstrictor tone in adults with elevated blood pressure [21] GÜR Ö，GURKAN S，YUMUN G，et al. The comparison
[J]. Hypertension，2016，67（6）：1196-1204. of the effects of nebivolol and metoprolol on erectile dys‐
[10] COATS A，JAIN S. Protective effects of nebivolol from function in the cases with coronary artery bypass surgery
oxidative stress to prevent hypertension-related target [J]. Ann Thorac Cardiovasc Surg，2017，23（2）：91-95.
organ damage[J]. J Hum Hypertens，2017，31（6）：376-381. [22] GUNGOR G，PERK H，SOYUPEK S，et al. Nebivolol

中国药房 2023年第34卷第16期 China Pharmacy 2023 Vol. 34 No. 16 · 2047 ·